Colin Love

Colin A. Love was the founder of Replimune Group, Inc. (founded in 2015) where he held the title of Chief Operating Officer from 2015 to 2024.
He is currently working as a Non-Executive Director at Freeline Therapeutics Ltd., as a Director at Replimune Ltd., and as a Director at Replimune (Ireland) Ltd. Dr. Love has previously worked as a Director-Manufacturing Development at Celltech Group Plc, as an Independent Non-Executive Director at Freeline Therapeutics Holdings Plc from 2021 to 2024, as a Vice President-Clinical Operations at Amgen, Inc. from 2011 to 2014, as a Senior Vice President-Product Development at BioVex, Inc. from 2000 to 2011, as a Senior Vice President-Product Development at BioVex Group, Inc. from 2000 to 2013, and as a Senior Vice President-Product Development at BioVex Ltd. Dr. Love has an undergraduate and doctorate degree from the University of Glasgow.